UK Markets closed

Medtronic plc (MDT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
108.55-0.23 (-0.21%)
At close: 04:00PM EST
107.17 -1.38 (-1.27%)
After hours: 07:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous close105.16
Bid107.16 x 1300
Ask0.00 x 1100
Day's range103.62 - 105.65
52-week range98.38 - 135.89
Avg. volume6,877,876
Market cap145.952B
Beta (5Y monthly)0.81
PE ratio (TTM)31.30
EPS (TTM)3.47
Earnings date22 Feb 2022
Forward dividend & yield2.52 (2.37%)
Ex-dividend date21 Dec 2021
1y target est131.64
  • Motley Fool

    1 Green Flag for Medtronic in 2022, and 1 Red Flag

    Medtronic (NYSE: MDT), is a global producer of medical technology and therapies, probably best known for its cardiac devices such as pacemakers -- and after two years of sudden, sharp dives in its stock prices, its investors are probably all too familiar with a racing heartbeat. This time, COVID-19's not to blame, but while the company is waving a green flag for investors, a darker red flag may take time to overcome. In February 2020, Medtronic acquired British AI and analytics specialist Digital Surgery to help bolster Medtronic's ambitions in robotic surgery.

  • Zacks

    Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

    Medtronic (MDT) closed at $108.95 in the latest trading session, marking a +0.98% move from the prior day.

  • Yahoo Finance Video

    BioMarin CEO: There are biotech companies 'that probably should not be on the market today’

    BioMarin CEO JJ Bienaimé joins Yahoo Finance Live’s Julie Hyman and Anjalee Khemlani to discuss the company's first gene therapy product targeted to patients dealing with hemophilia, the future of biotechnology, biotech stocks, and key takeaways from JPMorgan’s annual health care conference.